MC1R and autosomal erythropoietic protoporphyria: The only current treatment for EPP is afamelanotide, a melanocortin 1 receptor agonist that functions as an alpha-melanocyte stimulating hormone analogue to increase production of melanin [7], allowing for attenuation of sunlight so the EPP patient can have greater sun tolerance.